The Pharma Asia Conference 2026 officially kicked off, bringing together leading pharmaceutical visionaries, industry experts, and key stakeholders to discuss the future of healthcare and market expansion. A special moment as Pharma Asia representatives Mr. Farhan and Kaiser Waheed presented a bouquet of flowers to welcome Chairman PPMA Mr. Adnan Hirani, followed by the ribbon-cutting
PHARMA ASIA CONFERENCE 2026 Read More »
Pakistan and Ethiopia engage in key discussions focused on accelerating regulatory approvals and improving market access to bolster pharmaceutical exports and strengthen bilateral trade ties. PPMA remains committed to opening new trade corridors and expanding the footprint of high-quality Pakistani medicines across international markets.
EXPANDING PAKISTAN’S PHARMA REACH IN AFRICA Read More »
A landmark step towards patient safety and product authenticity! Effective 9th October 2026, 2D Barcodes and Serialization are now mandatory for all pharmaceutical products manufactured or imported into Pakistan. This progressive regulatory initiative: 🛡️ Curbs Counterfeit Medicines: Safeguards public health against substandard and fake drugs.🔍 Enables Traceability & Verification: Ensures full end-to-end supply chain tracking.📦
PAKISTAN INITIATES 2D BARCODE SYSTEM ON MEDICINES Read More »
The Pakistan Pharmaceutical Manufacturers Association (PPMA) successfully organized its 61st Annual General Meeting (AGM), bringing together key industry leaders, stakeholders, and office bearers. The event highlighted the official oath-taking ceremony of the newly elected leadership and Central Executive Committee (CEC), marking a dedicated step toward strengthening Pakistan’s healthcare ecosystem, advancing manufacturing standards, and driving growth
61ST ANNUAL GENERAL MEETING OF PPMA Read More »
Horizons for Pakistan’s Pharma Industry – From Domestic Strength to Global Competitiveness Organized by PPMA in collaboration with TerraBiz, the 9th Pakistan Pharma Summit will take place on November 25, 2026, at PC Hotel, Karachi, focusing on leveraging domestic capabilities to drive global competitiveness across the sector. Date: Wednesday, November 25, 2026 Timing: 9:00 AM
9TH PAKISTAN PHARMA SUMMIT 2026 Read More »
The 23rd Health Asia & Pharma Asia Exhibition kicked off at Karachi Expo Centre, gathering delegates and health experts from over 45 countries. PPMA member manufacturers continue leveraging global trade forums to build strategic B2B partnerships, adopt cutting-edge technology, and expand Pakistani pharmaceutical exports worldwide.
23RD HEALTH ASIA EXHIBITION Read More »
Federal Health Minister Syed Mustafa Kamal has announced that local production of vaccines and medical equipment will start soon, backed by $663 million investment agreements with Chinese companies. Pakistan currently exports medicines to 53 countries and is advancing toward WHO Maturity Level-3 accreditation, opening potential access to over 100 global markets.The Pakistan Pharmaceutical Manufacturers Association
LOCAL VACCINE & MEDICAL EQUIPMENT PRODUCTION SET TO BEGIN SOON Read More »
Despite completing DRAP registration and obtaining Cabinet Committee approval, vital cancer and specialty medicines remain legally unavailable across the country due to delayed price notifications. The Pakistan Pharmaceutical Manufacturers Association (PPMA) urges authorities to clear these pending price notifications immediately. Timely action is critical to prevent patients from relying on costly personal imports and to
URGENT CALL TO NOTIFY LIFE-SAVING DRUG PRICES Read More »
Federal Minister for Commerce Jam Kamal Khan chaired a high-level review, directing Foreign Trade Wings to formulate country-specific plans prioritizing pharmaceutical exports. The initiative focuses on resolving market-access barriers, improving trade logistics, and leveraging international trade missions to boost Pakistani pharma globally.
Action Plan to Expand Global Pharma Exports Read More »
Pakistan is moving toward WHO Maturity Level-3 accreditation by April 2027—a landmark step announced by Health Minister Syed Mustafa Kamal. PPMA fully supports DRAP and the Ministry of Health in unlocking new international trade opportunities and setting global regulatory standards.
From 52 to 100+ Global Markets! Read More »
Pakistan Pharmaceutical Manufacturer Association (PPMA) was established on January 26, 1961, and registered as the sole representative of the pharmaceutical industry on July 18, 1961.
